Recombinant Human Fucosyltransferase 9/FUT9 Protein, CF

FUT9 has been formulated so that it can be used in the cell surface glycoengineering of living cells, and does not affect cell viability or native phenotype apart from the intended impact on cell glycobiology
Catalog # Availability Size / Price Qty
9347-GT-020
R&D Systems Recombinant Proteins and Enzymes
1 Image
Product Details
Citations (1)
FAQs
Supplemental Products
Reviews

Recombinant Human Fucosyltransferase 9/FUT9 Protein, CF Summary

Learn more about Fluorescent Glycan Labeling and Detection

Product Specifications

Purity
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
Endotoxin Level
<1.0 EU per 1 μg of the protein by the LAL method.
Activity
Measured by its ability to transfer fucose from GDP-fucose to N-Acetyllactosamine The specific activity is >1,000 pmol/min/μg, as measured under the described conditions.
Source
Chinese Hamster Ovary cell line, CHO-derived human Fucosyltransferase 9/FUT9 protein
Thr33-Asn359
Accession #
N-terminal Sequence
Analysis
Thr33
Predicted Molecular Mass
39 kDa
SDS-PAGE
40-50 kDa, reducing conditions

Product Datasheets

You must select a language.

x

9347-GT

Carrier Free

What does CF mean?

CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.

What formulation is right for me?

In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.

9347-GT

Formulation Supplied as a 0.2 μm filtered solution in Tris and NaCl.
Shipping The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 6 months from date of receipt, -20 to -70 °C as supplied.
  • 3 months, -20 to -70 °C under sterile conditions after opening.

Assay Procedure

Materials
  • Glycosyltransferase Activity Kit (Catalog # EA001)
  • 10X Assay Buffer (supplied in kit): 250 mM Tris, 100 mM CaCl2, pH 7.5
  • MnCl2 (supplied in kit): 100 mM
  • Recombinant Human Fucosyltransferase 9/FUT9 (rhFUT9) (Catalog # 9347-GT)
  • GDP-Fucose (Sigma, Catalog # G4401), 1.6 mM stock in deionized water
  • N-acetyl-Lactosamine (V-Labs, Catalog # GN204), 50 mM stock in deionized water
  • 96-well Clear Plate (Catalog # DY990)
  • Plate Reader (Model: SpectraMax Plus by Molecular Devices) or equivalent
  1. Prepare 1X Assay Buffer containing 10 mM MnCl2 by combining 10X stocks and diluting 10 fold with deionized water.
  2. Dilute 1 mM Phosphate Standard provided by the Glycosyltransferase Kit by adding 40 µL of the 1 mM Phosphate Standard to 360 µL of 1X Assay Buffer for a 100 µM stock. This is the first point of the standard curve.
  3. Complete the standard curve by performing six one-half serial dilutions of the 100 µM Phosphate stock using 1X Assay Buffer. The standard curve has a range of 0.078 to 5 nmol per well.
  4. Prepare reaction mixture containing 0.16 mM GDP-Fucose, 0.6 mM Lactosamine, and 4 µg/mL Coupling Phosphatase 1 in 1X Assay Buffer.
  5. Dilute rhFUT9 to 1 µg/mL in 1X Assay Buffer.
  6. Load 50 µL of each dilution of the standard curve into a plate. Include a curve blank containing 50 μL of 1X Assay Buffer.
  7. Load 25 µL of 1 µg/mL rhFUT9 into empty wells of the same plate as the curve. Include a Control containing 25 μL of 1X Assay Buffer.
  8. Add 25 µL of the reaction mixture to all wells, excluding the standard curve. 
  9. Seal plate and incubate at 37 °C for 20 minutes.
  10. Add 30 µL of the Malachite Green Reagent A to all wells. Mix briefly.
  11. Add 100 µL of deionized water to all wells. Mix briefly.
  12. Add 30 µL of the Malachite Green Reagent B to all wells. Mix and incubate sealed plate for 20 minutes at room temperature.
  13. Read plate at 620 nm (absorbance) in endpoint mode.
  14. Calculate specific activity:

     Specific Activity (pmol/min/µg) =

Phosphate released* (nmol) x (1000 pmol/nmol)
Incubation time (min) x amount of enzyme (µg)

     *Derived from the phosphate standard curve using linear or 4-parameter fitting and adjusted for Control.

Per Reaction:
  • rhFUT9: 0.025 µg
  • Coupling Phosphatase 1: 0.1 µg
  • GDP-Fucose: 0.08 mM
  • Lactosamine: 0.3 mM

Background: Fucosyltransferase 9/FUT9

N-glycans, O-glycans and glycolipids are frequently fucosylated at terminal sites. Therefore, fucose is often part of a sugar epitope with important biological function. Well-known fucose-containing glycans include Lewis and ABO blood group antigens. Lewis epitopes are key elements involved in the leukocyte homing and extravasation process and thus are important for lymphocyte maturation and natural defense functions. Fucose-containing glycans also play critical roles in cell signaling and development (1). More than 10 fucosyltransferases have been cloned (2). FUT1 and FUT2 are alpha 1-2 fucosyltransferases and are responsible for ABO blood-group antigen synthesis. FUT8 is an alpha 1-6 fucosyltransferase that adds a fucose to the chitobiose core of N-glycans (3). FUT3, FUT4, FUT5, FUT6, FUT7 and FUT9 are alpha 1-3 or alpha 1-4 fucosyltransferases and are responsible for Lewis antigen generation. In particular, FUT9 synthesizes the Lewis X oligosaccharide (CD15) in the organ buds progressing in mesenchyma during embryogenesis and in mature granulocytes (4, 5). The activity of this enzyme has been measured with a phosphatase-coupled method (6).

References
  1. Jafar-Nejad, H. et al. (2010) Glycobiology 20:931.
  2. Becker, D.J. et al. (2003) Glycobiology 13:41R.
  3. Lee, S.H. et al. (2006) J. Biochem. 139:391.
  4. Kaneko M. et al. (1999) FEBS Lett. 452:237.
  5. Brito, C. et al. (2008) Biochimie. 90:1279.
  6. Wu, Z.L. et al. (2011) Glycobilogy 21:727.
Entrez Gene IDs
10690 (Human); 14348 (Mouse); 84597 (Rat)
Alternate Names
Alpha-(1,3)-Fucosyltransferase 9; alpha-(1,3)-fucosyltransferase; EC 2.4.1; EC 2.4.1.-; EC 2.4.1.65; fucosyltransferase 9 (alpha (1,3) fucosyltransferase); Fucosyltransferase 9; Fucosyltransferase IX; FucT-IX; Fuc-TIXFucT-IX; FUT9; Galactoside 3-L-fucosyltransferase

Citation for Recombinant Human Fucosyltransferase 9/FUT9 Protein, CF

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

1 Citation: Showing 1 - 1

  1. Fluorescent glycan fingerprinting of SARS2 spike proteins
    Authors: ZL Wu, JM Ertelt
    Scientific Reports, 2021-10-14;11(1):20428.
    Species: Human
    Sample Types: Recombinant Protein
    Applications: Bioassay

FAQs

No product specific FAQs exist for this product, however you may

View all Proteins and Enzyme FAQs
Loading...

Reviews for Recombinant Human Fucosyltransferase 9/FUT9 Protein, CF

There are currently no reviews for this product. Be the first to review Recombinant Human Fucosyltransferase 9/FUT9 Protein, CF and earn rewards!

Have you used Recombinant Human Fucosyltransferase 9/FUT9 Protein, CF?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review